Globally, gastrointestinal cancers represent more than one-fourth of all cancer incidence and one-third of cancer-related mortality. Although there has been much progress in …
E Morgan, M Arnold, A Gini, V Lorenzoni, CJ Cabasag… - Gut, 2023 - gut.bmj.com
Objective Colorectal cancer (CRC) is the third most common cancer worldwide. The geographical and temporal burden of this cancer provides insights into risk factor …
AMD Wolf, ETH Fontham, TR Church… - CA: a cancer journal …, 2018 - Wiley Online Library
Abstract In the United States, colorectal cancer (CRC) is the fourth most common cancer diagnosed among adults and the second leading cause of death from cancer. For this …
MCS Wong, J Huang, V Lok, J Wang, F Fung… - Clinical …, 2021 - Elsevier
Background & Aims We studied incidence and mortality trends of colorectal cancer (CRC) in 39 countries according to age, sex, and anatomic location (colon vs rectum). Methods We …
M Piñeros, M Laversanne, E Barrios… - The Lancet Regional …, 2022 - thelancet.com
Background Cancer is a leading cause of disease and death in Latin America and the Caribbean (LAC). Contemporary data on the cancer burden aims to inform effective cancer …
Excessive consumption of beverages sweetened with high-fructose corn syrup (HFCS) is associated with obesity and with an increased risk of colorectal cancer. Whether HFCS …
W Zhao, L Jin, P Chen, D Li, W Gao, G Dong - Cancer letters, 2022 - Elsevier
Compared with conventional chemotherapy and targeted therapy, immunotherapy has changed the treatment prospects of various solid tumors and has recently become the main …
Abstract Three‐dimensional (3D) bioprinting technology offers great potential in the treatment of tissue and organ damage. Conventional approaches generally rely on a large …
R Falz, C Bischoff, R Thieme, J Laessing… - Journal of cancer …, 2022 - Springer
Purpose Functional capacity is an independent indicator of morbidity in colon and rectal cancer surgery. This systematic review describes the evaluated and synthesized effects of …